Skip to main content

Table 2 Mental wellbeing prior and during COVID-19 pandemic

From: Impact of the COVID-19 pandemic on symptoms of anxiety and depression and health-related quality of life in older patients with chronic kidney disease

  Score rangea n Prior COVID-19 pandemic During COVID-19 pandemic p-value
Cross-sectional outcomes
Generic anxiety symptoms
  HADS-A score, median (IQR) 0–21 80 3.0 (0.0–6.0)  
  HADS-A score ≥ 8, n (%)   80 12 (15%)  
Longitudinal outcomes
Depressive symptoms
  GDS-15 score, median (IQR)b 0–15 81 0.0 (0.0–3.0) 0.0 (0.0–4.0) .028
  GDS-15 score ≥ 5, n (%) Yes/no 81 9 (11%) 18 (22%) .022
HRQoL
  MCS, mean (SD) 0–100 80 50.3 (9.6) 50.4 (9.9) .913
  PCS, mean (SD) 0–100 80 40.4 (10.1) 36.1 (10.4) <.001
  1. Abbreviations: GDS-15 15-item geriatric depression scale, HADS-A anxiety subscale of hospital anxiety and depression scale, HRQoL health-related quality of life, IQR inter-quartile range, MCS mental component summary, PCS physical component summary, SD standard deviation
  2. aHigher scores indicate more anxiety- or depressive symptoms, or better HRQoL
  3. For n = 23 patients who scored positive on Whooley questions both before and during the pandemic
  4. bWhere both Whooley questions were answered negative, we assumed GDS-15 score was 0